IntelliCyt Corporation specializes in developing and marketing high-throughput cell and bead-based screening solutions for the life sciences sector. Established in 2006 and based in Albuquerque, New Mexico, the company offers innovative products, including the iQue Screener platform, which integrates instruments, software, and reagents for high-content multiplexed analysis of cell and bead samples. IntelliCyt's ForeCyt software facilitates data visualization and analysis, while its MultiCyt screening kits provide essential reagents for use with iQue Screeners. These solutions significantly enhance the speed and cost-effectiveness of detecting and measuring cells, catering to the needs of pharmaceutical and biotechnology companies, as well as medical research institutions. By combining flow cytometry with patented sample processing technology, IntelliCyt has created a platform that accelerates suspension cell assays, enabling researchers to achieve higher productivity in drug discovery, antibody development, and toxicology studies. The company also provides installation, training, and technical support services to its clients. IntelliCyt operates as a subsidiary of Sartorius AG.
IntelliCyt Corporation specializes in developing and marketing high-throughput cell and bead-based screening solutions for the life sciences sector. Established in 2006 and based in Albuquerque, New Mexico, the company offers innovative products, including the iQue Screener platform, which integrates instruments, software, and reagents for high-content multiplexed analysis of cell and bead samples. IntelliCyt's ForeCyt software facilitates data visualization and analysis, while its MultiCyt screening kits provide essential reagents for use with iQue Screeners. These solutions significantly enhance the speed and cost-effectiveness of detecting and measuring cells, catering to the needs of pharmaceutical and biotechnology companies, as well as medical research institutions. By combining flow cytometry with patented sample processing technology, IntelliCyt has created a platform that accelerates suspension cell assays, enabling researchers to achieve higher productivity in drug discovery, antibody development, and toxicology studies. The company also provides installation, training, and technical support services to its clients. IntelliCyt operates as a subsidiary of Sartorius AG.